Skip to main content

Supplement Research and Comparison Website•Best Price Guarantee

Supplement Research and Comparison Website

D. Groeger

Alimentary Health Pharma Davos, Davos, Switzerland

Papers in database: 5
Primary author: 1 paper
Years active: 2013 – 2021
Health outcomes studied: 1

Health Outcomes Studied

Increased Regulatory T Cell Count

Papers (5)

2021
An Exopolysaccharide Produced by Bifidobacterium longum 35624® Inhibits Osteoclast Formation via a TLR2-Dependent Mechanism10.1007/s00223-020-00790-4
2018
Exopolysaccharide from Bifidobacterium longum subsp. longum 35624™ modulates murine allergic airway responses.10.3920/BM2017.0180
2016
Genome Analysis and Characterisation of the Exopolysaccharide Produced by Bifidobacterium longum subsp. longum 35624™10.1371/journal.pone.0162983
2016
The Surface-Associated Exopolysaccharide of Bifidobacterium longum 35624 Plays an Essential Role in Dampening Host Proinflammatory Responses and Repressing Local TH17 Responses10.1128/AEM.02238-16
2013Primary author
Bifidobacterium infantis 35624 modulates host inflammatory processes beyond the gut10.4161/gmic.25487